Endocrine pathology Flashcards

1
Q

DDx: insulin inj OD or insulinoma

A
  • Investigations: C-peptide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of diabetes mellitus

A
  • Type 1 DM
  • Type 2 DM
  • Other causes of DM:
    • Pancreatic disease
    • Hormonal antagonists to insulin (eg, cortisol, GH, catecholamines)
    • Drug - & chemical-induced
    • Genetic syndromes: Down’s, turner’s
  • Gestational DM (is typically resolved after delivery)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Etiology of Type I DM

A
  • Most cases of type 1 diabetes are caused by immune- mediated destruction of the pancreas -> insulitis
  • The reason for the autoimmune attack on the pancreatic beta-cells is unknown but genetic and environmental factors are important:
  • Genetic susceptibility:
    • concordance between monozygotic twins is 40%
    • association with HLA-DR3 & DR4/DQA1& DQB1
  • Environmental factors:
    • Association with viruses: coxsackie B4, Rubella, Mumps and some drugs and toxins

Autoimmunity:

  • Characterized by islet cell antibodies (ICA), other antibodies against pancreatic components and infiltration of the pancreatic islets by T-cells
  • There is a long pre-diabetic phase during which the destruction of  cells continues
  • The autoimmune system which destroys the pancreas is triggered by viral or chemical attack on beta cells, leading to exposing new proteins or due to molecular mimicry between viral and  cell structures. The HLA system is relevant because it is involved in antigen presentation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Etiology and Pathogenesis: Type 2 DM

A
  • caused by a combination of cell failure and Insulin resistance

Genetic Factors:

  • stronger than Type 1 (80 % concordance in identical twins).
  • no HLA associations
  • typically a polygenic disorder: depends on the simultaneous presence of several genes but environmental factors (eg obesity) are involved

Environmental factors:

  • Obesity is associated with around 80% of patients with Type 2 DM.
  • More than half of patients with diabetes have BMI between 25 – 29 kg/m2
  • Relative risk (RR) for DM for BMI >35kg/m2 100- fold than BMI <22 kg/m2
  • DM type II is rare at BMI 21-22
  • Increased FA and TNF in pathological state oppose action of insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
A

Pancreatic pathology in DM

Type 1 DM (left):

  • selective destruction of insulin-secreting beta cells surrounding Germinal Centre (GC); presence of GC makes it look like a LN.
  • insulitis, a chronic inflammatory infiltrate of the islets affecting primarily insulin containing islets.

Type 2 DM (right):

  • Moderate reduction islet tissue;
  • Fibrosis on periphery
  • Variable degrees of deposition of amyloid called amylin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical symptoms in DM

A
  • prominent in uncontrolled Type 1
  • Polyuria: osmotic diuresis
  • Nocturia
  • Thirst: dehydration
  • Weight loss: catabolic state
  • Tiredness: muscular weakness due to proteolysis and lack of glucose
  • Blurred vision: reversible dehydration of lens, and of aqueous and vitreous humour
  • Vomiting: ketones stimulate the area postrema
  • Hyperventilation (Kussmaul breathing): respiratory compensation to metabolic acidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnosis of DM

A
  • HbA1c > 6.5% (but A1c also elevated in other hemoglobinopathies)
  • Fasting plasma glucose (FPG) level > 126 mg/dL (7 mmol/L)
    • Best test for diabetes
  • Two-hour plasma glucose > 200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test (OGTT)
    • Good test for pre-diabetics: ​
    • Patient fasts overnight
    • Take basal glucose level
    • Give 75 gram glucose and measure blood glucose level at 120 minutes
  • Classical signs and symptoms (polyuria, polydipsia and unexplained weight loss), plus random glucose level > 200 mg/dL (11.1 mmol/L)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Prediabetic states

A
  • Impaired fasting glycaemia (IFG):
    • fasting plasma glucose above normal and below the diabetic range i.e. FPG > 100mg/dl but < 126 mg/dl (between 5.6 mmol/L and 6.9 mmol/L)
  • Impaired glucose tolerance (IGT):
    • 2-h value in the OGTT of > 140 mg/dl but < 20 mg/dl (between 7.8 and 11.1 mmol/L, during an OGTT)
  • A1c 5.7–6.4%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acute complications of DM

A
  • Hypoglycemia: complication of diabetes treatment
  • Diabetic ketoacidosis
  • Hyperosmolar nonketotic coma (HSS)
  • Lactic acidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PPt factors of DKA

A
  • Infection or acute illness
  • Trauma
  • Emotional disturbance
  • Missed insulin dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathophysiology of DKA:

A
  • vicious cycle of progressive metabolic disruption
  • Acute insulin deficiency, and the rise in stress hormones levels lead to progressive hyperglycaemia; severe hyperglycemia cause a huge osmotic diuresis and gross dehydration.
  • Acute insulin deficiency and the rise in levels of stress hormones (due to cellular starvation and hypovolemia) lead to development of ketosis. Ketosis cause vomiting.
  • Electrolyte disturbance is caused by (i) insulin deficiency (ii) osmotic diuresis (iii)vomiting
  • Acidosis is caused by (i) ketosis (ii) lactic acidosis, caused by dehydration and vasoconstriction by stress hormones.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of DKA

A
  • Saline infusion to replace fluids
  • Restore metabolic control
    • Insulin
    • potassium supplements
    • Bicarbonate “sometimes”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hyperosmolar hyperglycemic state (HSS)

A
  • Occurs in elderly patients with type 2 DM taking sweetened solutions (due to feeling hypoglycemic) leading to hypergycemic state
  • Relative insulin deficiency-sufficient to prevent ketosis but cannot suppress hyperglycaemia
  • Usually very high glucose levels causing dehydration.
  • Treatment: fluid replacement and insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Long-term complications of DM

A

Are caused by vascular complications which are divided into:

  1. Microangiopathy:

– affects capillaries, arterioles and small blood vessels

– Characterized by thickening of basement membranes, which causes leakiness

– manifestation: retinopathy, nephropathy, neuropathy

  1. Macroangiopathy

atherosclerosis in large-to-medium-size arteries that manifests as: ischemic heart disease, Stroke, peripheral vascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A

Diabetic nephropathy from Nodular glomerulosclerosis -> pathomnemonic of DM

  • Note: hyaline arteriolosclerosis also seen in lower right portion of image; macrovascular change
  • important cause of end-stage renal failure (ESRF)

Morphology: see renal FC for details

  • thickening of BM
  • leaky membrane
  • Kimmelstein-Wilson nodule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A

Diabetic retinopathy

  • commonest cause of blindness in adults between 30 and 65 years of age.

Morphology

  • microaneurysms
  • dot-blot spots -> retinal hemorrhages
  • advanced proliferative retinopathy with, exudates, neovascularization, and tractional retinal detachment
  • lost of pericytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Causes of hypopituitarism

A
  • Tumors: adenoma, craniopharyngioma, cerebral and secondary tumors
  • Vascular: Sheehan’s syndrome (delivery causes state of shock & hemorrhage), severe hypotension
  • Infection: meningitis, TB, syphilis, HIV/AIDS
  • Hypothalamic disorders: tumors, functional disorders, isolated deficiency of GHRH and LH/FSH-RH (GnRH secretion)
  • Iatrogenic: irradiation, hypophysectomy
  • Miscellaneous: sarcoidosis, hemochromatosis
  • Note: Panhypopituitarism may cause coma due to hypoglycemia or electrolyte imbalances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hyperprolactinemia

A

Causes

  • Physiological stress
  • Drugs: e.g. antipsychotics, oral contraceptive pill, antidopamine drugs
  • Tumors: Prolactinoma, Stalk section which removes inhibitory signal on prolactin secretion
  • Renal failure
  • Ectopic source

Clinical features and investigation

  • Gonadal dysfunction:
    • amenorrhea or anovulation, infertility
    • decreased libido, erectile impotence in men
  • Galactorrhea
  • Investigations:
    • Blood levels of prolactin
    • MRI or CT scanning
  • Treatment: initially medications but surgery may be needed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acromegaly

A
  • almost always due to adenoma (v. rarely ectopic GHRH )
  • GF-1 effects on chondrocytes -> bone protrusions (no linear growth after puberty)
  • GH opposes insulin

Sx:

  • bitemporal hemianopsia due to local effects of pituitary adenoma
  • hypertension,
  • arthritis
  • headaches
  • menstrual disturbances
  • loss of libido and loss of potency in men
  • diabetes mellitus

Investigations:

  • serum IGF-1
  • OGTT: failure of suppression or a paradoxical rise in GH suggests acromegaly.

**C&C: **

  • carpal tunnel sundrome,
  • cardiac failure
20
Q

Diabetes insipidus (DI)

A
  1. Central DI; caused by absolute deficiency of ADH:

– genetic
– hypothalamic or high pituitary stalk lesion
– idiopathic

  1. Nephrogenic DI; caused by resistance to ADH action

– genetic
– metabolic: hypokalemia, hypercalcemia
– Drugs: Lithium

21
Q

SIADH

A

Presentation: Hyponatremia can be asymptomatic or associated with nonspecific symptoms.

Severe hyponatremia, specially if there is rapid fall in serum sodium, can cause neurological symptoms, coma and death.

Causes

– Post-operative

– Intra-cranial disease: encephalitis, meningitis, head injury

– Neoplasms: eg small cell carcinoma of the lung

– Pulmonary disease: pneumonia, tuberculosis

– Drugs/Medications

22
Q

Hyperthyroidism (thyrotoxicosis)

A

Histo

  • scalloped colloids w a lot empty spaces in bw -> glands are more active
  • decreased colloid due to consumption in the formation of papillary projections lined by tall columnar cells and INCREASED TH production

Causes

  • Grave’s disease: the most common cause:
    • – is an autoimmune disease with HLA associations
    • – Causes goiter with diffuse enlargement
    • – Characterized by ophthalmopathy and pretibial myxedema
    • – thyroid stimulating immunoglobulins which bind TSH receptors
  • toxicadenoma
  • toxic multinodular goiter
  • thyroiditis: inflammation destroys acini and causes TH release (gland is not hyperactive)
    • – Subacute (De Quervain’s) thyroiditis: pain, tenderness, fever
    • – Postpartum thyroiditis due to natural immunosupression during pregnancy
  • Functional thyroid cancer (produces thyroid hormones)

Sx (partial list)

  • diffuse goitre
  • proximal myopathy
  • Lid-lag
  • Menstrual disorders and infertility
  • Effects on heart (arrhythmias) and bone (osteoporosis)
  • Diarrhea
  • Characteristic sx to Graves and due to deposition of mucopolysacchrides
    • Pretibial myxdema -> hyperthyroidism; (Genereal myxdema -> hypo)
    • Exophthalmos
    • Acropachy: tenderness and clubbing in wrists

Dx: Thyroid stimulating immunoglobulins (TSI) occur in Grave’s disease

C&C

  • thyroid storm: arrhythmia, pyrexia, heart failure
  • TH sensitizes effects of catecholamines on CVS and CNS via increase catecholamine receptors
23
Q

Thyroid adenoma

A

Gross: solitary thyroid nodule, spherical lesion that compresses the adjacent non-neoplastic thyroid

Histo:

  • variable sized follicles
  • acellular collagenous area -> capsule
  • upper image -> normal tissue
  • lower image -> well-differentiated neoplasm

Etiopath:

  • somatic mutations in the TSH receptor signaling pathway
  • mutations of RAS; genetic alterations shared with follicular carcinomas.

Sx: functional (toxic nodule is rare) or non-functional

24
Q
A

Hashimoto’s disease

  • *Microscopic**
  • Mononuclear lymphocytes surrounding Germinal centres; follicles in bw
  • oxyphil (PTH producing) & Hurthle cells (associated with Hashimoto’s thyroiditis[1] as well asfollicular thyroid cancer)
  • Type IV Hypersensitivity

Sx: weight gain, hoarseness of voice changes, depressed, apathetic, bradycardia, cold intolerance, slowed reflex, alopecia, galactorrhea, infertility, generalised myxdema, hypoPrl, CTS, psychosis

Cretinism: protruberant abdomen, characterstic cry, short stature, coarse dry skin, lack of teeth, protruding tongue, mental retardation

Dx: antimicrosomal and antithyroglobulin antibodies are present in

high titres in Hashimoto’s disease

C&C: lymphoma

25
Q
A

Follicular carcinoma

Histo:

  • Invade the capsules and spread into blood vessels
  • smaller and scalloped follicles; variable sized
  • Herthle cells
  • Well differentiated follicles, which can be difficult to tell apart from normal thryoid tissue

Etiopath:

  • cause: iodine deficiency
  • RAS mutation
  • hematogenous spread

Sx: functional carcinomas rare so more important to check for hematogenous spread to lungs

26
Q
A

Papillary carcinoma of thyroid

Gross image: multifocal papillary masses

Histo (left):

  • papillary shape of follicles
  • psammoma bodies

Histo (right):

  • Large thyrocytes w dense nucleus & clear cytoplasmaaka “Orphan Annie eyes” due to dispersion of chromatin

Etiopath:

  • most common thyroid carcinoma
  • cause: radiation
  • spread: lymphatic

Sx: functional nodule are -> check for cervical LN enlargement

27
Q

Anaplastic carcinoma of thyroid

A
  • in elderly females
  • quickly growing -> suffocating
28
Q
A

Medullary carcinoma of the thyroid

Gross

  • Solitary or multifocal
  • Multicentricity in familial type

Microscopic

  • Tumour cells surrounded by extracellular deposition of amyloid.
  • polygonal to spindle-shaped cells, which may form nests, trabeculae, and even follicles
  • originates from the parafollicular cells (also called C cells) of the thyroid; they produce calcitonin

Etiopath

  • Occurs in the following clinical Settings:
  • Sporadic- accounts for 80% of all cases of medullary thyroid cancer.
  • Part of Multiple Endocrine Neoplasia Syndromes (MEN 2A or MEN 2B)
  • inherited medullary carcinoma not associated with endocrine disorders.

Sx:

  • Cervical lymphadenopathy (LAD)
  • Voice hoarseness
  • Dysphagia
  • Watery diarrhea
  • Paraneoplastic syndrome

Dx

  • total thyroidectomy; Calcitonin measurement is useful in monitoring of treatment
29
Q

Adrencortical insufficiency

A

aka Primary Adrencortical insufficiency

Causes

– autoimmune disease, affecting the adrenal gland alone or in association with other autoimmune diseases eg thyroid disease, premature ovarian failure and type 1 DM

– infections: TB, AIDS, meningitis ( causing Water-house- Fridericksen syndrome), which cause hemorrhage and destruction of the adrenal glands)

– Bilateral secondary carcinoma

  • Secondary adrenal insufficiency, usually due to pituitary disorders. Not associated with hyperpigmentation or electrolytes disturbances

Sx: tiredness, weakness, anorexia, apathy, abdominal pain, hyperpigmentation, postural hypotension

Adrenal crisis:

  • circulatory shock, volume depletion, anorexia, nausea and vomiting
  • precipitated by infection

Dx:

  • low cort, aldosterone, Na+, and bicarb
  • high RAS
30
Q

Cushing’s syndrome: Hypercortisol (Hyperadrenal)

A

Causes

– Exogenous steroids

– Pituitary dependent

– Adrenal adenoma

– Ectopic ACTH

Sx (Selected list)

  • Hypertension
  • Thin limbs and muscular weakness due to proteolysis
  • Impaired glucose tolerance
  • Psychiatric disturbances
  • Menstrual disturbances
  • osteoporosis, kyphosis, fractures -> hypercalcemia
  • Edema

Dx

  1. 24 hour urinary free cortisol: commonly used screening test
  2. DST: 1 mg Overnight DEX
    * Normal individuals typically have very low levels of cortisol in these samples (<50 nmol/L), indicating that ACTH secretion is suppressed, while cortisol level is not suppressed in patients with Cushing’s disease
  3. Late-night salivary cortisol: new test
  4. Low-dose DST: 2 mg DEX/day for 2 d: To exclude hypercortisolism caused by depression, obesity and alcoholism.

After the diagnosis of Cushing’s syndrome is established, the source of excess cortisol needs to be determined:

  1. high-dose DST: 8 mg DEX overnight or 2 day 8 mg DEX
    * Plasma ACTH
    * Localization: MRI or CT scan
31
Q
A

Adrenal cortical adenoma

Gross

  • small tumour (1 to 2 cm)
  • usually non-functional
  • elder, obese, women
  • can result in hyperaldosteronism (Conn syndrome) -> -ve feedback on RAS -> low renin
  • Adenoma (benign, most of the cases), hyperplasia, carcinoma

Sx: sodium retention leading to hypertension, hypokalemia and metabolic alkalosis

Dx

A. Case detection: Aldosterone: renin ratio (ARR)

B. Confirmatory tests:

    1. Oral Na+ loading test
    1. Fludrocortisone Suppression test (FST)

C. CT scan: Unilateral or bilateral micro-or macro-adenoma or bilateral hyperplasia

D. Adrenal venous sampling: For lateralizing the source of excess aldosterone

32
Q

Secondary hyperaldosteronism

A

caused by increased activity of the renin-angiotensin system, in response to decreased effective blood volume as in liver cirrhosis, heart failure and nephrotic syndrome or due to decreased renal

blood flow in some forms of hypertension

33
Q

CAH: CYP21 deficiency

A
  • approximately 95% of cases

Presentations

  1. Simple virilizing (non salt-losing CAH):

– Girls: ambiguous genitalia. (often born with an enlarged clitoris and the labia may be partially fused

– Boys: Normal at at birth. Penile enlargement, early pubic hair and rapid growth in height when the child is 4 or 5 years old.

  1. Adrenal crisis (salt-losing CAH): occurs when aldosterone production blocked leading to circulatory collapse, vomiting
  2. late-onset CAH: hirsutism, infertility

**Investigation **

  • high level of 17 - hydroxyprogesterone in blood in a morning sample.
  • Urinarysteroidprofile
34
Q

CAH: CYP11 Beta-hydroxylase deficiency

A
  • causes features of androgen excess, including ambiguous genitalia and virilization in females and precocious puberty in male children.
  • Most patients also have **hypertension **due to weak mineralocort activity of deoxcort.
35
Q

CAH: CYP17alpha hydroxylase deficiency

A
  • causes decreased production of glucocorticoids and sex steroids and increased synthesis of mineralocorticoid precursors.
  • Reduced levels of both gonadal and adrenal sex hormones result in ambiguous genitalia in males.
  • In females, there is delayed puberty, absent secondary sexual characteristics, or primary amenorrhea
  • Excessive mineralocorticoid activity produces varying degrees of hypertension and hypokalemia.
36
Q

Neuroblastoma

A
  • A common childhood tumour ( aaproximately 8% of childhood malignancies)
  • occurs mostly in the adrenals, occasionally in the sympathetic chain.
  • Histology-variable
  • Most common product is dopamine and metabolite
  • homovanillic acid (HVA), but catecholamines are secreted
  • I-123 (MIBG) scintigraphy: concentrates in >90% of the tumors and therefore used in the assessment of spread and response to therapy
37
Q
A

Pheochromatocytoma

Morphology

  • hyperplasia of chromaffin
  • nest of cells aka “Zellballen bodies (pathomnemonic)
  • *Etiopath:**
  • NF & RET
  • Rule of 10: 10% familial, 10% bilateral, 10% extra-adrenal (sympathetic chains), 10% malignant
  • tumor of Chromaffincells.
  • Secretes mostly adrenaline and noradrenaline and rarely dopamine
  • The 10% rule (approximate rule): 10% extraadrenal; 10% inherited; 10% malignant; 10% bilateral; 10 in childhood;10% component of multiple endocrine neoplasia, MEN2a and MEN2b.
  • *Sx:**
  • neurofibroma
  • sympathomimetic sx (DDx w thyrotoxicosis)

Dx:

  • Measure catecholamines and their metabolites in a 24- hour urine collection
  • MRI or CT scanning: for localization of tumor
  • I-123-metaiodobenzylguanidine (MIBG) scintigraphy:
  • *C&C:**
  • renal injury & nephrosclerosis
  • sudden cardiac deaths
  • stroke
38
Q

Hypercalcemia

A

Causes

90% of cases of genuine hypercalcemia are due to two causes:

  1. Hyperparathyroidism 2. Malignant disease

Other causes:

  • Excessive vitamin D:-vitamin D intoxication
  • Granulomas (tuberculosis, lymphoma, sarcoidosis) because they activate vitamin D by hydroxylation.
  • High bone turnover: thyrotoxicosis or Paget’s disease

Sx:

  • Asymotomatic: One half of patients are asymptomatic
  • Renal
    • – Polyuria and thirst (dry mouth)
    • – Stones
    • – Nephrocalcinosis; deposition of calcium crystals in kidney
    • – May lead to renal failure
  • Musculoskeletal
    • – Muscle weakness
    • – Rarely demineralization, subperiosteal bone resorption, bone cysts (osteitis fibrosa cystica)
  • Neurological
    • – Psychiatric/neurological symptoms
  • Gastrointestinal
    • – Anorexia, constipation and ulcers

Dx

  • Plasma calcium (usually total calcium is measured)
  • Plasma phosphate
  • Plasma alkaline phosphatase,
  • Plasma PTH
  • Management:
    • – Correct dehydration
    • – Furosemide
    • – Biphosphonates
    • – Calcitonin
39
Q

Hyperparathyroidism

A
  • Primary hyperparathyroidism: mostly solitary adenoma, rarely hyperplasia or carcinoma
  • Secondary hyperparathyroidism:
    • is the reaction of the parathyroid glands to a hypocalcemia caused by something other than a parathyroid pathology
  • Tertiary hyperparathyroidism:
    • occurs when PTH increases to maintain normocalcemia in the setting of vitamin D deficiency ; eventually parathyroid hyperplasia occurs and PTH secretion becomes independent of calcium level; often seen in patients with chronic renal failure.
  • Hyperparathyroidism can be part of multiple endocrine neoplasia (MEN1 and MEN2 syndromes)
  • Malignancy-induced
    • PTHrP more common than ectopic PTH clinically
    • Bone metastasis: local cytokine secretion or PG cause bone destruction
    • Humoral hypercalcemia of malignancy: many solid tumours secrete PTHrP -> hypercalcemia
    • 1,25 dihydroxy vit. D hypercalcemia 2o to lymphomas that express 1alpha-hydroxylase.

Investigations

  • Plasma calcium (usually total calcium is measured)
  • Plasma phosphate
  • Plasma alkaline phosphatase,
  • Plasma PTH (might be in nl range)
40
Q

Hypocalcaemia

A

Causes

  • Hypoalbuminemia (will cause a low total plasma calcium but the ionized calcium level will be normal)
  • Chelation by EDTA
  • PTH-related: hypoparathyroidism, pseudohypoparathyroidism, hypomagnesemia
  • Defect in vitamin D metabolism: rickets, osteomalacia, Chronic renal failure, vitamin D resistant rickets, liver disease, anticonvulsive therapy
  • Acute pancreatitis

Sx

  • increased neuromuscular excitability with tetany, parathesia and muscle cramps.
  • prolonged hypocalcaemia is associated with cataract, mental retardation, psychosis, increased intracranial pressure and seizures.
41
Q

Hypoparathyroidism

A

Causes

  • Congenital absence of parathyroid glands: Ex. Di-George syndrome which also cause underdevelopment of thymus, and congenital heart defects.
  • autoimmune syndrome; Could be associated with other autoimmune problems eg adrenal and ovarian failure
  • Thyroidectomy or neck surgery
  • Pseudohypoparathyroidism: decreased responsiveness of target organs because of problems with PTH receptors. Sex-linked; males affected twice as often as females.

Sx

  • Skeletal features : short stature, short metacarpals and short metatarsals
  • Other features: cataracts, mental retardation and testicular atrophy
42
Q

Hypophosphatemia

A

Causes

  • Chronic alcohol abuse
  • Malabsorption
  • Incr cell uptake: treated diabetic ketoacidosis, hyperalimentation alkalosis
  • Incr excretion: hyperparathyroidism, hypomagnesaemia, renal tubular defect, dialysis
  • Dilution: vol expansion

Sx

  • Muscle weakness
  • Hemolysis
    • – depletion of 2,3-diphosphoglycerate
  • Respiratory failure
    • Severe hypophosphatemia in critically ill patients
    • need to correct phosphate levels before restoring respiration
  • Rhabdomyolysis: Myoglobin released by muscle destruction may lead to acute renal failure.
43
Q

Hyperphosphatemia

A

Causes

  • Artefactual – hemolysis or delay in separation of blood samples
  • Chronic renal failure
  • Hypoparathyroidism

Sx: High plasma calcium and phosphate levels promote metastatic calcification in non-normal tissue -> complications: heart failure

44
Q

Hypomagnesemia

A
  • associated with hypocalcaemia and/or hypokalemia

Causes: malabsorption, malnutrition, alcoholism, diuretics,chronic mineralocorticoid excess

Sx of hypomagnesmia: Tetany, agitation, ataxia, tremors, convulsions

45
Q

Hypermagnesemia

A

Causes:

  • renal failure is the most important cause
  • eclampsia rx w MgPO4

Sx: High levels > 6 mg/L can cause respiratory paralysis and cardiac arrest

46
Q

MEN

A
  • Familial condition in which 2 or more endocrine tumor types, occur as a part of one of the defined MEN syndromes; MEN1 and MEN2 are AD disorders
  • MEN1 aka Wermer’s syndrome: mutation in the MEN1, tumor-suppressor gene
    • 3 Ps: tumors predominanntly in the anterior pituitary, parathyroid and pancreatic islets.
    • Parathyroid tumors
    • Entero-pancreatic endocrine tumors (Gastrinoma, Insulinoma, Vipoma, Glucagonoma)
    • Pituitary tumor (mostly prolactinoma).
    • Other endocrine and non-endocrine neoplasms including adrenocortical and thyroid tumors, lipomas, and carcinoids
  • MEN2: mutations in the RET proto-oncogene.
    • MEN2 has three clinical variants referred to as MEN2A, MEN2B and MTC only.
    • MENIIa (1M,2Ps): MedullaryThyroidCancer(MTC), Pheochromocytoma, Parathyroid adenoma
    • MENIIb (2Ms,1P): MedullaryThyroidCancer,Marfanoid habitus/mucosal neuroma, Pheochromocytoma
    • MTC only

*